Magnetic Resonance Imaging-Guided Online Adaptive Lattice Stereotactic Body Radiotherapy in Voluminous Liver Metastasis: Two Case Reports

被引:9
|
作者
Dincer, Neris [1 ]
Ugurluer, Gamze [1 ]
Korkmaz, Latif [2 ]
Serkizyan, Anatolia [1 ]
Atalar, Banu [1 ]
Gungor, Gorkem [2 ]
Ozyar, Enis [3 ,4 ]
机构
[1] Acibadem Univ, Radiat Oncol, Istanbul, Turkey
[2] Acibadem Maslak Hosp, Radiat Oncol, Istanbul, Turkey
[3] Acibadem Mehmet Ali Aydinlar Univ, Sch Med, Radiat Oncol, Istanbul, Turkey
[4] Acibadem Hosp, Radiat Oncol, Istanbul, Turkey
关键词
lattice; mr-linac; sbrt; inoperable; liver metastasis; RADIATION-THERAPY; LUNG-CANCER;
D O I
10.7759/cureus.23980
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Lattice Radiotherapy (LRT) is a technique in which heterogeneous doses are delivered to the target so large tumors can have optimal doses of radiation without compromising healthy tissue sparing. lb date, case reports and case series documented its application for bulky tumors mainly in the pelvic region. LRT not only provides dosimetric advantages but also promotes tumor control by triggering some radiobiological and immunological pathways. We report two cases of giant liver metastases for whom other treatment options were not suitable. We treated both patients with Magnetic Resonance Image-Guided Radiotherapy (MRgRT) with online adaptive LRT (OALRT) technique. Adaptive plans were generated before each fraction. Tumors were observed to have regressed interfractionally so the location and number of spheres were adapted to tumor size and daily anatomy of the surrounding organs at risk (OAR). Both patients had good treatment compliance without any Grade 3+ side effects. They are both under follow-up and report improvement. By reporting the first application of OALRT by using MRgRT in liver metastases, we show that MRgRT is a promising modality for LRT technique with better target and OAR visualization as well as online adaptive planning before each fraction according to the daily anatomy of the patient.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Online adaptive planning for prostate stereotactic body radiotherapy using a 1.5 Tesla magnetic resonance imaging-guided linear accelerator
    Yang, Jinzhong
    Vedam, Sastry
    Lee, Belinda
    Castillo, Pamela
    Sobremonte, Angela
    Hughes, Neil
    Mohammedsaid, Mustefa
    Wang, Jihong
    Choi, Seungtaek
    PHYSICS & IMAGING IN RADIATION ONCOLOGY, 2021, 17 : 20 - 24
  • [2] Magnetic Resonance Imaging-Guided Adaptive Radiotherapy for Colorectal Liver Metastases
    Romesser, Paul B.
    Tyagi, Neelam
    Crane, Christopher H.
    CANCERS, 2021, 13 (07)
  • [3] Stereotactic magnetic resonance imaging-guided radiotherapy for intracardiac metastases: A case report
    Michaleta, M.
    Tetreau, R.
    Pasquie, J. -l.
    Chabre, O.
    Azria, D.
    CANCER RADIOTHERAPIE, 2024, 28 (02): : 202 - 205
  • [4] Magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer: more than a simple "MIRAGE"?
    Bosetti, Davide Giovanni
    Angrisani, Antonio
    Castronovo, Francesco Mose
    Pesce, Gianfranco Angelo
    Zilli, Thomas
    TRANSLATIONAL CANCER RESEARCH, 2023, 12 (10) : 2454 - 2457
  • [5] Dosimetric Benefit of Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Liver Metastases
    Weykamp, Fabian
    Katsigiannopulos, Efthimios
    Piskorski, Lars
    Regnery, Sebastian
    Hoegen, Philipp
    Ristau, Jonas
    Renkamp, C. Katharina
    Liermann, Jakob
    Forster, Tobias
    Lang, Kristin
    Koenig, Laila
    Rippke, Carolin
    Buchele, Carolin
    Debus, Juergen
    Klueter, Sebastian
    Hoerner-Rieber, Juliane
    CANCERS, 2022, 14 (24)
  • [6] Magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer (mirage): a phase iii randomized trial
    Ma, Ting Martin
    Lamb, James M.
    Casado, Maria
    Wang, Xiaoyan
    Basehart, T. Vincent
    Yang, Yingli
    Low, Daniel
    Sheng, Ke
    Agazaryan, Nzhde
    Nickols, Nicholas G.
    Cao, Minsong
    Steinberg, Michael L.
    Kishan, Amar U.
    BMC CANCER, 2021, 21 (01)
  • [7] Magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer (mirage): a phase iii randomized trial
    Ting Martin Ma
    James M. Lamb
    Maria Casado
    Xiaoyan Wang
    T. Vincent Basehart
    Yingli Yang
    Daniel Low
    Ke Sheng
    Nzhde Agazaryan
    Nicholas G. Nickols
    Minsong Cao
    Michael L. Steinberg
    Amar U. Kishan
    BMC Cancer, 21
  • [8] Stereotactic magnetic resonance-guided online adaptive radiotherapy in kidney oligometastases
    Laouiti, Mohamed
    Mazouni, Zohra
    Salati, Emanuela
    Durigova, Anna
    RADIOTHERAPY AND ONCOLOGY, 2024, 197 : S295 - S296
  • [9] 1.5-Tesla Magnetic Resonance-Guided Adaptive Stereotactic Body Radiotherapy for Liver Malignancies
    Onal, C.
    Yavas, G.
    Yavas, C.
    Arslan, G.
    Efe, E.
    Haberal, M.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1117 - S1117
  • [10] Stereotactic Magnetic Resonance-guided Online Adaptive Radiotherapy for Oligometastatic Breast Cancer: A Case Report
    Tyran, Marguerite
    Cao, Minsong
    Raldow, Ann C.
    Dang, Audrey
    Lamb, James
    Low, Daniel A.
    Steinberg, Michael L.
    Lee, Percy
    CUREUS, 2018, 10 (03):